New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...

Targeting the WNT signaling pathway represents a promising strategy for cancer therapy. The field has evolved to include numerous inhibitors currently under preclinical and clinical investigation.

Druggable phosphatases in cancer and immune cells, with examples of their corresponding drugs. Structures of allosteric inhibitors targeting PP2A, PRL3, DUSP1/6, and SHP2 in cancer cells (left).

The research has been published in Molecular Cancer Therapeutics. The study showed for the first time that inhibiting two key cancer signaling pathways at the same time, the PI3K and mTOR pathways, ...

Colorectal tumors that underwent somatic next-generation sequencing (NGS) for 154-168 genes in an in-house laboratory between 2015 and 2022 were retrospectively identified. Microsatellite instability ...

Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, and resistance to therapy due to their innate capacity for self-renewal and ...

Scientists at The Wistar Institute and ChristianaCare’s Helen F. Graham Cancer Center & Research Institute have uncovered a ...

Children with lesions on the top or back of the tongue often face significant challenges with eating and speaking. With ...

Beyond weight loss, GLP-1s may offer a "two-for-one" benefit by protecting heart health, which is the leading cause of ...

Lifestyle and chemical exposures-from diet to pesticides, herbicides-are increasingly linked to rising colon cancer rates in ...